Tempus AI, Inc.
TEMHealthcareNASDAQHealth Information Services
Scan Results
Daily timeframeTempus AI, Inc. operates as a healthcare technology company in the United States. At a $11.60B market cap, Tempus AI, Inc. ranks as a large-cap company within healthcare. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests.
Market Cap
$11.60B
Beta
3.72
P/E (TTM)
—
P/E (Fwd)
-2675.41
EPS (TTM)
$-1.44
EPS (Fwd)
$-0.02
ROE
-67.4%
ROA
-8.6%
Cash
$816.0M
Total Debt
$1.44B
Free CF
-$93.5M
52W Change
-17.3%
Annual Financials
Cash vs Debt
Where TEM stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, TEM finished 18.39% above its 150-day moving average ($52.32) and 9.74% above its 200-day moving average ($56.44). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is TEM overbought or oversold?
At the September 3, 2026 close, TEM's RSI(14) was 57.9, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
On the balance sheet, TEM has $816.0M in cash with $1.44B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. The company is burning cash, with free cash flow at -$93.5M. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. Return on equity stands at -67.4%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has grown from $320.7M (2022) to $1.27B (2025), reflecting a 297% increase over the period.
A beta of 3.72 means TEM is more volatile than average. Investors should be prepared for wider price swings relative to broader indices. Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Tempus AI, Inc.'s trajectory.